Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ProtFlav and ProtCent in Hemorrhoids
NCT03569930Phase 4Unknown
- Sponsor
- Sapienza University of Rome
- Start
- May 2018
- Primary completion
- Dec 2018
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in Hemorrhoids (3 arms), sponsored by Sapienza University of Rome. Primary endpoint: Delta of time necessary for the disappearance of bleeding at 3 months. Status: unknown.
02
Conditions
Hemorrhoids
Beyond the preview
Go deeper on NCT03569930.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03569930.